Drug Development Journey for Macrophage-Directed Therapies Through QPCTL: a Novel Drug Target to Modify the CD47 Immune Checkpoint

Time: 12:00 pm
day: Innate Immune Checkpoints & Activation Pre-Focus Day

Speakers: